Sorry, you need to enable JavaScript to visit this website.

    Pfizer Invites Public to Listen to Teleconference on Important Update Related to Chantix ® (varenicline)

    (BUSINESS WIRE)--Pfizer Inc invites media and investors to listen to a teleconference related to CHANTIX at 1:15 PM US/EST on Wednesday, July 1. In addition to providing an update on CHANTIX, Pfizer scientists will answer press questions on the information provided.

    To listen to the teleconference, please use relevant dial-in number and passcode as listed below.

    Participant joining details
    International direct dial-in number      +1 857 3501687
    US Dial-in number      1 866 7881317
    Passcode:      696 082 70#

    Participants are advised to call the dial-in to pre-register in advance of the conference call. Pre-registration for the teleconference will be available at 1:00 PM US EST.

    If you have trouble registering or accessing the conference, please contact Lauren Hoffman at 212-733-0785.

     

     

     

    Pfizer Inc
    Media
    Sally Beatty, 212-733-6566
    or
    Investor
    Suzanne Harnett, 212-733-8009



     

     

     

    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now